www.PennyStockScholar.com Reports Breakout Stocks:Clean Power Concepts Inc. (OTCBB: CPOW), Diversified Holdings Corporation (PINKSHEETS: ADHC), Advanced Cell Technology, Inc. (OTCBB: ACTC)
Sign-Up for our FREE Stock Picks AND OUR AWARD WINNING NEWSLETTER at www.PennyStockScholar.com
Visit: www.PennyStockScholar.com for current profiles.
Clean Power Concepts Announces New Consumer Health Product
REGINA, Saskatchewan, Dec. 23, 2010 Clean Power Concepts Inc. ('Clean Power' or the 'Company'), (OTC Bulletin Board: CPOW), announced today its Spirit of Health line has launched production of Omega 3 100% Virgin Camelina Oil ('Virgin Camelina Oil').
Clean Power's CEO Michael Shenher commented, "The Spirit of Health Virgin Camelina Oil is a gourmet consumer product which is an excellent 'health conscious' substitute for other salad dressings and cooking oils. We produce this oil ourselves by cold pressing from the seeds of Camelina Sativa and then bottle and distribute. Virgin Camelina Oil production leverages our expertise in seed crushing, further diversifies our revenues, and this high margin product is another step forward toward our goal of producing a unique range environmentally friendly consumer products."
Camelina contains high levels of omega 3, omega 6 and vitamin E and is generally viewed to be superior to flax oil, and many fish oils, and does not have the risk of mercury contamination. The Camelina Sativa plant, sometimes called "Gold of Pleasure," is also known as "False Flax," or "Wild Flax." Camelina is a very rich source of Polyunsaturated Fatty Acids (PUFA's) and this property makes it an excellent choice for nutraceutical use. Additionally, its high EFA (essential fatty acid) and linoleic acid content is known to have good effects on skin, and is believed to act as an anti-age and emollient agent which can improve skin elasticity and suppleness.
Shenher concluded by saying, "This product addition is another example of the innovation we're striving to achieve at Clean Power. Our environmentally friendly products range from industrial lubricants to consumer food items. We see this diversification as both a strength and a sensible way to fulfill growing demand at all levels for products which are based on renewable supply chains and don't harm the environment."
About Clean Power Concepts Inc.
Clean Power Concepts Inc. was incorporated in Nevada on October 17, 2005 and trades on the OTC-BB under the symbol CPOW. To implement expansion of our business in the environmentally friendly green energy industry we acquired 95.1% of General Bio Energy Inc. based on a share exchange concluded on April 29, 2010. General Bio was incorporated in Saskatchewan, Canada on February 14, 2006 and operates a fully integrated commercial oilseed crushing, bio-diesel refinery, and environmental lubricants manufacturing and bottling, and nutraceutical and food processing plant in Regina, Saskatchewan. The current plant has a crush capacity of 19.7 million liters of crushed oil annually. Its biodiesel fuel processor can produce up to 20 million liters of biofuel and biofuel additives and the crushing system can produce nearly 32.8 thousand metric tonnes of meal and protein related products for agricultural and aquaculture feedstock annually. The plant is capable of specialty and toll crushing a wide variety of oil seeds. General Bio's primary brand is 'MOPO Environmental Lubricants' and other key trade names include: 'General Bio Health' and 'Spirit of Health', under which General Bio manufactures, distributes, and retails essential oils, camelina, canola, flax, and hemp, in various formats including capsules, gourmet cooking oils, and skin care formulations.
CAUTIONARY STATEMENT ON FORWARD-LOOKING INFORMATION
Safe Harbour Statement under the Private Securities Litigation Reform Act of 1995
Certain information contained in this press release, including any information as to our strategy, plans or future financial or operating performance and other statements that express management's expectations or estimates of future performance, constitute "forward-looking statements." All statements, other than statements of historical fact, are forward-looking statements. The words "believe," "expect," "will," "anticipate," "contemplate," "target," "plan," "continue," "budget," "may," "intend," "estimate," "project" and similar expressions identify forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain cost adjustments and/or delays beyond the company's control with respect to bio energy manufacturing operations, changes in the worldwide price of agricultural commodities, crude oil, and/or certain other commodities; regulatory, legislative, political or economic developments in the jurisdictions in which the Company carries on business; operating or technical difficulties in connection with bio energy manufacturing operations or development activities; employee relations; transportation logistics; and the unpredictability of risks involved in the newly developing bio energy industry. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law.
Visit: www.PennyStockScholar.com for current profiles.
Leading mHealth Software Developer, American Diversified Holdings, Unveils 2011 Business Plan on Corporate Website
www.AmericanDiversifiedHoldings.com Updated to Include PowerPoint Business Plan Outlining 2011 Corporate Direction to Enter the 170 Billion Alzheimer's and Dementia Related Treatment Industry
DEL MAR, Calif., Dec. 23, 2010 Ernest Remo, CEO of American Diversified Holdings Corporation (Pink Sheets:ADHC) announced today that the company has completed a complete overview of the company's 2011 Business Plan and has uploaded it to the corporate website. Management has been in extensive strategy sessions with its advisory team for the past several weeks resulting in an extensive plan to bring ADHC's mHealth software concept to the market. Shareholders and other interested parties are encouraged to review the plan on the website to gain further insight into ADHC's plan to enter the $170 billion Alzheimer's and dementia related treatment industry.
Ernest B. Remo, Chairman/CEO of ADHC, said, "With all the recent developments and announcements at ADHC, we felt it was in our investors' best interest to lay out in detail the Corporate strategy for the next twelve months to give the investor community a concise idea of how we plan to implement this strategy."
The Overview can be found at www.AmericanDiversifiedHoldings.com (click on Investors tab, followed by Presentation tab)
American Diversified Holdings Corporation
American Diversified Holdings Corporation is developing a platform for the Mobile Health Care Market as the medical profession gears up to go electronic not only for medical records but also for direct patient monitoring and information. ADHC's mHealth Division will Focus on Mobile Health Care Applications for iPhone(TM), iPad(TM), Android(TM) and Other Mobile Devices. ADHC is developing applications for the iPhone, iPad, Android and Other Mobile Devices tailored for specific ailments and protocols to allow medical professionals to monitor patients, get instant feedback and constantly adjust treatments to allow greater flexibility and response time in meeting individual patient needs. mHealth or mobile Health is a term used for the practice of medical and public health, supported by mobile devices. The term is most commonly used in reference to using mobile communication devices, such as mobile phones for Health Services and information.
This press release contains forward-looking statements pursuant to the "safe harbor" provisions of the Private Securities Litigation Act of 1995. These statements include risks and uncertainties that may cause the Company's plans to change and are in no way intended to guarantee that the Company will be successful in executing its plans. American Diversified Holdings common stock currently trades on the over the counter "Pink Sheets" under the symbol ADHC. This press release in no way constitutes any recommendation regarding the securities of ADHC or its affiliates. Any person reading this press release is advised that this release should be considered in the light of all the facts and circumstances regarding the business and financial condition and prospects of ADHC, and no inference has been made that this release contains all such information.
Visit: www.PennyStockScholar.com for current profiles.
Advanced Cell Technology and The Roslin Institute Announce Agreement for Storage and Distribution of Embryonic Stem Cells Using ACT's Blastomere Technology
Embryonic Stem Cells Made Using Proprietary "Embryo-Safe" Technique To Be Made Available for Companies and Researchers Worldwide
MARLBOROUGH, Mass. 12/27/2010 Advanced Cell Technology, Inc. ("ACT"; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that it has entered into a Memorandum of Understanding with Roslin Cells LTD ("Roslin Cells") of Scotland, in which the two companies contemplate a definitive collaboration agreement in the near future. They will work together to establish a bank of Good Manufacturing Practice (GMP)-grade human embryonic stem cell (hESC) lines using ACT's proprietary "single-ceblastomere" technique for deriving embryonic stem cells without damage to the embryo.
The collaboration contemplates that the hESC lines will be created and stored using protocols that meet the regulatory standards of the European Medicines Agency (EMA) and United States Food and Drug Administration (FDA). Roslin Cells will be responsible for maintaining the banked hESC lines, which will be made available for both research and commercial purposes. By utilizing GMP and careful characterization and documentation of the resulting hESC lines, it is intended that the banked hESC lines will be suitable to move readily from laboratory settings into clinic programs, thereby speeding translation research into human treatments. Predictability in price and commercialization terms is a key feature of the goals of the collaboration. Roslin Cells will promote access to the hESC lines from the bank as research reagents to both academic and commercial entities. In addition, ACT and Roslin Cells will publish a commercialization license so that third parties will have a reasonable and predictable path to commercialization of products using the same hESC lines that they may use in animal model studies for preclinical data. Commercialization licenses will also provide access to the cell lines biologics master file in order to establish regulatory compliance. Proceeds from commercialization licenses, including milestone and royalty payments, will be shared between ACT and Roslin Cells.
"The relationship with Roslin Cells has grown out of our initiatives in Europe over the past year, and comes as part of our close efforts with the Scottish Development agency. Along with the recent announcement of our European Orphan drug designation filing in our Stargardt's disease treatment program, the relationship with Roslin Cells signals the expansion of our commercial initiatives in Europe, and, more broadly, markets around the world," said ACT's Interim Chairman and CEO, Gary Rabin. "Roslin Cells is already one of the leading organizations in GMP manufacturing of stem cells. Through the creation of hESC lines derived using our proprietary 'embryo-safe' technique, we fully expect Roslin Cells to quickly become a leading hESC bank for Europe, North America and Asia. We foresee major demand for these embryonic stem cells from both researchers and commercial interests across the globe."
"Until we developed our single blastomere technology, embryonic stem cell research had been synonymous with the destruction of human embryos," stated Robert Lanza, MD, Chief Scientific Officer at ACT. "In stark contrast to embryonic stem cells lines currently available for research, such as those on the NIH registry, our single blastomere technique does not destroy the embryo. One of the benefits to an ability to create new hESC lines without destroying embryos is that it addresses ethical concerns of certain researchers."
The Company's single blastomere technique relies on isolating a single cell from a 4 to 8 cell embryo utilizing a one-cell biopsy approach similar to that used in pre-implantation genetic diagnostics (PGD). According to recent literature, one-cell biopsy as part of PGD is carried out routinely around the world, and one to two thousand children are born every year in the United States and Europe after being conceived by in vitro fertilization using one-cell biopsy and PGD.
"The availability of our 'embryo safe' hESC lines has sparked interest in many quarters, including at institutions that have been opposed to conducting embryonic stem cell research in the past," continued Dr. Lanza. "We are exploring opportunities to provide our cells to those institutions.
About Advanced Cell Technology, Inc.
Advanced Cell Technology, Inc. is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit http://www.advancedcell.com.
About Roslin Cells
Roslin Cells Ltd was established in 2006 by the Roslin Institute with the support of the University of Edinburgh, the Scottish National Blood Transfusion Service and Scottish Enterprise. The company's core mission is to provide ethically sourced, pluripotent human cells manufactured to the highest quality available according to Good Manufacturing Practice (GMP standards). Roslin Cells has been independently verified according to rigorous standards and successfully attained ISO 9001:2008 certification in February 2009 (Certificate Number: FS 544151). Since then, the company has continued to demonstrate their meticulous standards, with successful annual renewals of their Human Tissue Authority (HTA) and Human Fertilization and Embryology Authority (HFEA) licenses Roslin Cells is headquartered in Roslin, Midlothian, and is a not for profit organization. Further information can be found at www.roslincells.com.
Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-K for the year ended December 31, 2009. Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change. Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.
Visit: www.PennyStockScholar.com for current profiles.
www.PennyStockScholar.com is the premier stop for investors who wish to experience huge profits via investing in microcap and small cap stocks with huge profit potential.
Penny Stock Scholar's goal is to inform you about the hottest stocks before the rest of the market catches on. PennyStockScholar.com email report service is free to those investors who sign up on our website.
Penny Stock Scholar's Alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to stocks that trade on OTC, OTCBB, NYSE, NASD, and AMEX exchanges, that have the potential of showing increased activity. To subscribe to this free service, visit the Penny Stock Scholar home page at http://www.PennyStockScholar.com and Sign up Free For "Daily Stock Alerts".
Join us at http://www.PennyStockScholar.com for a complimentary subscription to the most exciting online financial newsletter.
Disclaimer: Verify all claims and do your own due diligence. PennyStockScholar.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockScholar.com is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. PennyStockScholar.com is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), PennyStockScholar.com is owned and operated by PennyStockScholar.com. Neither PennyStockScholar.com nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this press-release, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since PennyStockScholar.com receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in PennyStockScholar.com statements and opinions and such statements and opinions cannot be considered independent. PennyStockSchol.com and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. PennyStockScholar.com services are often paid for using free-trading shares. PennyStockScholar.com may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.
Visit us for a full Disclaimer at: http://www.pennystockscholar.com/disclaimer.html
To feature your publicly traded company in our alerts, email us at: office@PennyStockScholar.com
Investors can receive their FREE Newsletter subscription by clicking here: http://www.PennyStockScholar.com
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to email@example.com)).